Omicron Covid | Page 3 | Vital Football

Omicron Covid

UK number of people with long Covid for more than a year has passed 500,000

An estimated 1.3 million people in the UK – one in 50 – had long Covid in early December, the highest number since estimates began, PA Media reports.

This includes more than half a million people who first had Covid-19, or suspected they had the virus, at least one year ago.

The figures, from the Office for National Statistics (ONS), are based on self-reported long Covid from a representative sample of people in private households.

Responses were collected in the four weeks to 6 December – before the recent surge in infections driven by the Omicron variant.

The estimate of 1.3 million people is up from 1.2 million at the end of October and 945,000 at the start of July.

Of the 1.3 million, 892,000 people (70%) first had – or suspected they had – Covid at least 12 weeks previously, while 506,000 (40%) first had the virus at least a year earlier.

Long Covid is estimated to be adversely affecting the day-to-day activities of 809,000 people – nearly two-thirds of those with self-reported long Covid – with 247,000 saying their ability to undertake day-to-day activities has been “limited a lot”, the ONS found.

Fatigue continues to be the most common symptom (experienced by 51% of those with self-reported long Covid), followed by loss of smell (37%), shortness of breath (36%) and difficulty concentrating (28%).

People working in teaching and education showed a greater prevalence of self-reported long Covid than other professions, and also saw the biggest month-on-month increase, from 2.7% to 3.1%.

For people working in healthcare, the figure dropped from 3.3% to 3.0%, and for people in social care it fell from 3.6% to 3.4%.

Among different age groups, the biggest jumps were for children aged 12 to 16, where prevalence rose month-on-month from 1.4% to 1.9%, and for 35- to 49-year-olds, up from 2.6% to 2.8%.

Self-reported long Covid is defined as symptoms persisting for more than four weeks after the first suspected coronavirus infection which could not be explained by something else.
 
An interesting update by a cardiologist who advises 11 football clubs. Players who have had covid have a 1 in 1000 chance of suffering heart problems. Whereas 1 in 20,000 could suffer from the same issues after vaccination. He also suggested a player might need 3 to 6 months rest before returning to full output. In summary vaccination is safer than catching covid.
 
An interesting update by a cardiologist who advises 11 football clubs. Players who have had covid have a 1 in 1000 chance of suffering heart problems. Whereas 1 in 20,000 could suffer from the same issues after vaccination. He also suggested a player might need 3 to 6 months rest before returning to full output. In summary vaccination is safer than catching covid.

Afraid footballers aren't the smartest. Around 500,00 people are still suffering long covid symptoms (as I believe to a much lesser extent now I am), and I had the vaccine, so cannot know, but doubt I'd have even got through it without the vaccines.

Afraid many footballers have set the tone for many in their teens. twenties etc and many now are regretting not having it - a new variant is on the agenda now, a new variant that is a mix of Delta and Omicron - this, when it takes off here, could be the true killer, I hope I'm wrong.
 
Last edited:
What Covid does to the brain – and what you can do to prevent it

The virus wreaks havoc through the inflammatory responses in the body, but it’s not all bad news

By Professor James Goodwin 10 January 2022 • 5:00am

070122_MON_HEALTH_PORTAL_trans_NvBQzQNjv4BqqVzuuqpFlyLIwiB6NTmJwfSVWeZ_vEN7c6bHu2jJnT8.jpg

During infection, the virus enters the brain as a kind of ‘Trojan horse’

In early 2020, after three days in a London hospital undergoing treatment for Covid, an apparently well 55-year-old woman was discharged home. But all was not well.
Within 24 hours she became confused and disorientated and began behaving oddly, going through repetitive behaviours such as putting her coat on and taking it off – again and again. She hallucinated, seeing lions and monkeys prowling around the house. She became deluded, believing that an identical impostor had taken the place of her husband. She began hearing things. And she became episodically aggressive. She had become psychotic. She was just one of many patients who, in the earliest stages of the pandemic, showed apparent recovery from Covid only to be struck down by serious neurological, behavioural or psychiatric disorders.
If physicians at the outset of the Covid pandemic didn’t expect to see neurological symptoms – headache, loss of smell or taste, delirium and ‘brain fog’ – in what is essentially a respiratory disease, they really shouldn’t have been surprised. History is replete with examples of virus-related neurology.
We’ve known for a while Covid has powerful psychological impacts. Simply being diagnosed with the disease incurs significant stress and anxiety – which can trigger depression. Covid diagnosis and treatment is likely to be more traumatic than for other conditions, owing to the severity of the illness, its novelty and the associated fear and uncertainty. And these stresses become compounded by the subsequent social isolation, in which the comfort and support of family and friends are removed.
But it is also known that there is an association between the impairment of the immune system and mental health.
Covid wreaks its havoc through the inflammatory responses in the body. The deadliness of the infection is attributable as much to the aggressiveness of our own immune system as to the effects of the disease itself. We may unleash upon ourselves an inflammatory response of such severity that it threatens our recovery and even our life.
TELEMMGLPICT000254275408_trans_NvBQzQNjv4BqHgTv8HPfBVpZECAYOC1TI_EeTFgPXoiyxxl0vFVRUd4.jpeg

Professor Goodwin is director of science and research impact at the Brain Health Network Credit: Penguin
When we breathe the Sars-CoV-2 virus into our lungs, our immune system swings into action. If you are healthy, Covid infection and the destruction of lung cells triggers a local immune response. White blood cells including macrophages and monocytes are recruited, substances called cytokines are released, and adaptive T and B immune cells are primed.
In most cases, this process is capable of resolving the infection. But if you are unhealthy (if, for example, you are suffering from long-term illnesses such as obesity or diabetes) and/or you are older (say, over 75) and/or your immune system is impaired, or if your infection results from a huge viral load, then a very different story may unfold. There is likely to be an uncontrolled immune response – the release of a large dose of inflammatory molecules (a ‘cytokine storm’), a massive influx of immune cells to the infected area and a failure of the body to inhibit pro-inflammatory responses.
The cytokine storm mainly affects our lungs, and can lead to acute respiratory distress syndrome, eventually respiratory failure – and sadly, for many, death. It’s not only the lungs that are affected: many other organs are damaged, from the liver to the heart to the kidneys. This is both directly because of low oxygen, and indirectly by their own local inflammation and blood clotting. The brain is not exempt from this.
About one in five Covid patients show serious cerebral (brain) vascular events, such as strokes, TIAs and blocked blood vessels, as a result of circulating micro-embolisms (travelling blood clots) and increased clotting factors in the blood.
But further, we know now that during infection, the virus enters the brain as a kind of ‘Trojan horse’. It enters through the highly impermeable blood-brain barrier (BBB) – the tightly sealed blood vessels which protect the brain. The virus spike locks on to the ACE2 receptors of the vessels, replicates inside its cells and then passes through the BBB into the brain. Further, both local and body-wide inflammation conspire to break down the BBB, including damaging its communication with the immune system. There is some good news, however: it appears that though the virus gets into the brain’s neurons, it doesn’t kill them; and the insulation of white matter cells is left intact.
People recovering from Covid, or those with long Covid, talk about having ‘brain fog’ – a non-medical term used by people when they feel spaced out, sluggish or fuzzy. As well as the result of inflammation, this could also be because, as new research shows, the virus damages the mitochondria of our brain cells – the powerhouses of our cellular energy. Mitochondria make up 10 per cent of our body weight, and provide more than 95 per cent of our energy for all bodily functions, from fighting infection to metabolising food.
Is it all bad news, and is there anything we can do to fix our brains?
On an optimistic note, recent research shows that the mitochondria are extremely resilient. They have a double system of repair: via their own internal mechanisms, and via help from the cell nucleus.
It’s also within our power to look after our brains. Avoiding infection in the first place – chiefly by being fully vaccinated – is clearly the most important thing. But if you’ve had a Covid infection, you have some power over the preservation of mitochondrial function, and the recovery of your brain power. Since the outbreak of the pandemic, more than 20,000 scientific papers have been published. Thankfully, they show not only how we may defeat the virus but inspiringly, how we may counteract its effects.
The following measures are backed up by research:
Lower your calorie intake (but not your intake of nutrients)
This reduces the output of reactive oxygen species which drive inflammation and cellular damage. Aim to establish a healthy calorie range to prevent overeating – a reduction of about 10 per cent is recommended.
Fast intermittently
Intermittent fasting supports the mitochondrial network by removing damaged mitochondria and triggering biogenesis (manufacture) of new mitochondria.
Avoid regular sugar ‘boosts’
Astonishingly, certain neurons in the brain ‘feel’ a sudden rise in glucose levels (a ‘sugar rush’). Their mitochondria rapidly change their shape and structure and this can lead to profound overall metabolic change such as type 2 diabetes. Lowering the consumption of refined carbohydrates and sugars will remove this pressure on our precious mitochondria.
Eat healthy foods
Certain foods contain nutrients which support healthy brain cells by boosting their enzymes. Examples are omega-3 fatty acids (cold-water, fatty fish), alpha-lipoic acid (grass-fed red meat, liver, spinach, broccoli), and L-cartinine and creatinine (lean red meat, poultry, eggs, nuts, beans, seeds).
Take regular exercise
This will force your brain cells to generate energy, and is especially important as we get older, because there is an incipient loss of mitochondria as we age (1–2 per cent per year from middle age onwards). Exercise will reduce this trend and even reverses mitochondrial loss. After a period of consistent exercise mitochondria increase in number and are more capable of generating energy. Do what you can - from a brisk walk with the dog, to an hour’s hard work in the garden.
Take regular saunas
Try two or three times a week for 10-15 minutes at a time. Research has shown that increasing the temperature of muscle tissue increases the efficiency of mitochondria.
Get a good night’s sleep
This is about more than not feeling tired. Hormones such as corticosteroids, which act to regulate our mitochondria, are extremely sensitive to the disruption of our daily rhythms. Relaxation and meditation can play a part in keeping our mitochondria healthy by reducing the psychological effects of stress hormones, such as cortisol.
Try essential oils
Research has found that carvacrol, found commonly in the essential oils of thyme, oregano, black cumin and wild bergamot has been reported to inhibit the activity of ACE2 proteins - thus blocking the entry of the Covid virus - and has anti-viral, anti- inflammatory, anti-oxidant and immune-moderating properties.
 
Hospital numbers with covid are at their highest since last February at just under 20,000.Is this a resurgence of Delta or is Omicron not as mild as its reported to be ?
 
Hospital numbers with covid are at their highest since last February at just under 20,000.Is this a resurgence of Delta or is Omicron not as mild as its reported to be ?

The driver is Omicron; it's extremely contagious - roughly about x5 or 6x than the last variant; but it is milder, most especially for those who've had their jabs. A disregard for basic safeguards across our behavior patterns is helping to fuel it ( some idiots are even going out of their way to get in the hope of 'super-immunity').

Locally, our hospital breakdown goes something like this (as of last week) 70-80% of hospitalizations are people who either aren't vaccinated or only had one jab, some double jabbed, but almost none (no matter what age) who've had the booster. The age profile now and health conditions are/were mostly 20 , 30 and 40 somethings, but in the last week or so it's now got to the more elderly i.e. 50+ and that's driving admissions.

As for IC, nearly 90% of cases are nonvaccinated and they can overwhelmingly be broken down to mostly ethnic minorities, the rest are people with age and co-morbidities.

The bigger issue than just the death toll, is the huge rise in long term covid sufferers which is being fuelled by the 20's, 30's and 40's who have caught it and then found issues/symptoms that are not improving even tough according to the tests they now longer have it - this is the real ticking timebomb for the NHS/society in general - no one knows how we're going to treat so many going forward across so many specialisations.

Until we have a new multi-faceted vaccine, I don't think these serious issues will be under real control for years - so many now seem to think that because this variant is 'milder' it will become just like the flu or cold, the problem is we've never seen a virus mutate at these speeds, so the next one might be deadly and far more contagious.
 
In COVID, New-Onset Seizures More Common Than Breakthrough Seizures

Randy Dotinga

An analysis of hospitalized patients with COVID-19 finds that those with no history of epilepsy had more than 3 times the odds of suffering a new-onset seizure than patients with epilepsy were to have breakthrough seizures (odds radio [OR] 3.15, P < .0001), researchers reported at the annual meeting of the American Epilepsy Society.
"If you have COVID and you have a seizure, it's more likely that you're having it for the first time, and it's not as likely that you have epilepsy," study lead author Neeraj Singh, MD, a neurologist at the New York-based Northwell Health system, said in an interview. "That's new. We don't normally see that when someone has a bacterial or viral infection. It's demonstrating that this infection is having direct effect on the brain and brain signals."
According to Singh, there's little data about seizures in patients with COVID-19 because doctors have focused on other symptoms. A 2021 multicenter study found that electrographic seizures were detected in 9.6% of 197 patients with COVID-19 who were referred for cEEG.

For the new study, Singh and a colleague tracked 917 patients with COVID-19 in the Northwell Health system who were treated from Feb. 14 to June 14, 2020, with antiepileptic medication. Of the patients, 451 had a history of epilepsy, and 466 did not.

According to Singh, 27.6% of the patients without a history of epilepsy had new-onset seizures, while 10.1% of the patients with history of epilepsy had breakthrough seizures. The difference in odds was more than threefold after adjustment. (Among all COVID-19 patients, he said, perhaps 8%-16% had seizures).
The researchers also found that patients with new-onset seizures stayed in the hospital much longer (average, 26.9 days) than any patients with a known history of epilepsy (12.8 days, P < .0001, for those who had breakthrough seizures and 10.9 days, P < .0001, for those who didn't).
In addition, the researchers found that having any seizures – new-onset or breakthrough – was linked to higher risk of death (OR 1.41, P = .03).
Antiseizure medications are key treatments for these patients, Singh said. As for the patients with new-onset seizures who recover from COVID-19, Singh said, "it's suspected that these people are going to have a new diagnosis of epilepsy, not just a one-time seizure."
The findings suggest that some patients with epilepsy are protected against COVID-19-related seizures because they take antiepileptic medications that "protect the brain from getting a trigger for an abnormal signal that leads to a seizure," he said. "That's one possibility."
What can neurologists learn from the study? Singh recommends a "lower threshold" to recommend or approve EEGs in patients with COVID-19 who are confused/altered when they come in, especially if this is not normal. "They may actually be having silent seizures that no one's noticing," he said.
No study funding was reported. The authors reported no relevant disclosures.
 
In COVID, New-Onset Seizures More Common Than Breakthrough Seizures

Randy Dotinga

An analysis of hospitalized patients with COVID-19 finds that those with no history of epilepsy had more than 3 times the odds of suffering a new-onset seizure than patients with epilepsy were to have breakthrough seizures (odds radio [OR] 3.15, P < .0001), researchers reported at the annual meeting of the American Epilepsy Society.
"If you have COVID and you have a seizure, it's more likely that you're having it for the first time, and it's not as likely that you have epilepsy," study lead author Neeraj Singh, MD, a neurologist at the New York-based Northwell Health system, said in an interview. "That's new. We don't normally see that when someone has a bacterial or viral infection. It's demonstrating that this infection is having direct effect on the brain and brain signals."
According to Singh, there's little data about seizures in patients with COVID-19 because doctors have focused on other symptoms. A 2021 multicenter study found that electrographic seizures were detected in 9.6% of 197 patients with COVID-19 who were referred for cEEG.

For the new study, Singh and a colleague tracked 917 patients with COVID-19 in the Northwell Health system who were treated from Feb. 14 to June 14, 2020, with antiepileptic medication. Of the patients, 451 had a history of epilepsy, and 466 did not.

According to Singh, 27.6% of the patients without a history of epilepsy had new-onset seizures, while 10.1% of the patients with history of epilepsy had breakthrough seizures. The difference in odds was more than threefold after adjustment. (Among all COVID-19 patients, he said, perhaps 8%-16% had seizures).
The researchers also found that patients with new-onset seizures stayed in the hospital much longer (average, 26.9 days) than any patients with a known history of epilepsy (12.8 days, P < .0001, for those who had breakthrough seizures and 10.9 days, P < .0001, for those who didn't).
In addition, the researchers found that having any seizures – new-onset or breakthrough – was linked to higher risk of death (OR 1.41, P = .03).
Antiseizure medications are key treatments for these patients, Singh said. As for the patients with new-onset seizures who recover from COVID-19, Singh said, "it's suspected that these people are going to have a new diagnosis of epilepsy, not just a one-time seizure."
The findings suggest that some patients with epilepsy are protected against COVID-19-related seizures because they take antiepileptic medications that "protect the brain from getting a trigger for an abnormal signal that leads to a seizure," he said. "That's one possibility."
What can neurologists learn from the study? Singh recommends a "lower threshold" to recommend or approve EEGs in patients with COVID-19 who are confused/altered when they come in, especially if this is not normal. "They may actually be having silent seizures that no one's noticing," he said.
No study funding was reported. The authors reported no relevant disclosures.
My girlfriend has epilepsy and has had 2 full seizures within a month after none for maybe a year. She also lost her sense of smell and taste. She has a chronic cough which she is about to have a new inhaler for, diagnosed as asthma. She has no energy and wheezes frequently.
She's fully jabbed up including booster.
 
My girlfriend has epilepsy and has had 2 full seizures within a month after none for maybe a year. She also lost her sense of smell and taste. She has a chronic cough which she is about to have a new inhaler for, diagnosed as asthma. She has no energy and wheezes frequently.
She's fully jabbed up including booster.

Has she had covid then - at least if she was aware of it; these are the types of outcomes from covid infection in relatively young people that are going through the roof - but in fairness mainly from the unvaccinated.
 
Has she had covid then - at least if she was aware of it; these are the types of outcomes from covid infection in relatively young people that are going through the roof - but in fairness mainly from the unvaccinated.
Not that she is aware of. She already had asthma and epilepsy but both have got worse recently, in fact after her booster.
 
Not that she is aware of. She already had asthma and epilepsy but both have got worse recently, in fact after her booster.

If she didn't have any reactions to the first two, it's extremely unlikely the booster would have been a root cause, but it is always worth discussing it with the GP as it sounds like her health might be deteriorating?
 
If she didn't have any reactions to the first two, it's extremely unlikely the booster would have been a root cause, but it is always worth discussing it with the GP as it sounds like her health might be deteriorating?

She couldn't get to speak to a GP. Got palmed off with a phonecall with the nurse at the practice. Prescribed a new inhaler. Didn't even want to see her.
 
She couldn't get to speak to a GP. Got palmed off with a phonecall with the nurse at the practice. Prescribed a new inhaler. Didn't even want to see her.

Have to say, few GP's have covered themselves in glory since this pandemic started. That's dreadful, hate to say it, she probably needs to try and again exaggerate her symptoms; if she lost her sense of taste and smell, even if you didn't know she almost certainly had covid and she is now suffering from a known long covid after effect . She needs to press that onto the doctor i.e. the long covid worry or they'll just keep fobbing her off.
 
Why are we seeing so many health issues in stadiums now ?

Having been a regular at Spurs for over 40 years , i can only remember a few times when we had medical emergencies in the stadium for fans

Recently , lots of games are being stopped due to medical problems in the stands

Is this due to covid ?
 
Why are we seeing so many health issues in stadiums now ?

Having been a regular at Spurs for over 40 years , i can only remember a few times when we had medical emergencies in the stadium for fans

Recently , lots of games are being stopped due to medical problems in the stands

Is this due to covid ?

I wouldn't say it is, 'issues' so far have all been mature adults (the paying football going public to the PL continues to age apace) actual in-stadium incidents are lower than the last know statistic (2016), but the pre-drink routine is often heavier now as is the incidence of Cocaine use at grounds - many suppliers use football grounds as an ideal outlet/exchange market, as it's almost impossible to Police, but it's known it's a key element of feeding county gangs supply chains.

https://www.thesun.co.uk/sport/1716...hugs-surge-violence-exclusive-stadium-tested/

So, I'd look for the cause elsewhere at the moment until one of the incidents can be related to covid - which so far, none have.
 
I never considered football matches for drug trafficking but yes, it's an ideal scenario.
I used to deliver finger print scanners for every Glastonbury festival where the police had in situ cells for drug crimes.
I would have thought football matches would be targeted in a similar way.
 
I never considered football matches for drug trafficking but yes, it's an ideal scenario.
I used to deliver finger print scanners for every Glastonbury festival where the police had in situ cells for drug crimes.
I would have thought football matches would be targeted in a similar way.

Clubs have to pay for policing, so do the bare minimum with lowly paid stewards, one club I know had to sack most of them for the involvement in illegal substances, and then quickly said it was due to new stewarding policies - I laughed my head off as the MD was telling me that one.

Police do have undercover officers at many grounds now, but they just gather the intelligence and pass it on, I know one Women Police officer who is part of busting the county lines gangs and she thinks trafficking at the PL clubs is on a massive scale.
 
A Texas team comes up with a COVID vaccine that could be a global game changer

baylor-vaccine_pr-6083-8a990dc125f751a3b9f8b8086f2cb10948a8f4f6-s1100-c50.jpg


Dr. Peter Hotez and Dr. Maria Elena Bottazzi of Texas Children's Hospital and Baylor College of Medicine have developed a COVID-19 vaccine that could prove beneficial to countries with fewer resources.
Max Trautner/Texas Children's Hospital

A vaccine authorized in December for use in India may help solve one of the most vexing problems in global public health: How to supply lower-income countries with a COVID-19 vaccine that is safe, effective and affordable.

The vaccine is called CORBEVAX. It uses old but proven vaccine technology and can be manufactured far more easily than most, if not all, of the COVID-19 vaccines in use today.

"CORBEVAX is a game changer," says Dr. Keith Martin, executive director of the Consortium of Universities for Global Health in Washington, D.C. "It's going to enable countries around the world, particularly low-income countries, to be able to produce these vaccines and distribute them in a way that's going to be affordable, effective and safe."

The story of CORBEVAX begins some two decades ago. Peter Hotez and Maria Elena Bottazzi were medical researchers at George Washington University in Washington, D.C., where they worked on vaccines and treatments for what are called neglected tropical diseases, such as schistosomiasis and hookworm.

When a strain of coronavirus known as SARS broke out in 2003, they decided to tackle that disease. After moving to Houston to affiliate with Baylor College of Medicine and the Texas Children's Center for Vaccine Development, they created a vaccine candidate using protein subunit technology. This involves using proteins from a virus or bacterium that can induce an immune response but not cause disease.



"It's the same technology as the hepatitis B vaccine that's been around for decades," Hotez says.


Goats and Soda
The goal: at least 40% vaxxed in all nations by year-end. This map shows how we stand

Their SARS vaccine candidate looked promising, but then the SARS outbreak petered out. No evidence of disease, no need for a vaccine.

When a new strain of coronavirus triggered the COVID-19 pandemic, Hotez and Bottazzi figured they could dust off their old technology and modify it for use against COVID-19. After all, the virus causing COVID-19 and the virus causing SARS are quite similar.

Hotez says they tried to interest government officials in the vaccine, but they weren't impressed.

"People were so fixated on innovation that nobody thought, 'Hey, maybe we could use a low-cost, durable, easy-breezy vaccine that can vaccinate the whole world,' " Hotez says.

"We really honestly couldn't get any traction in the U.S., but our mission is always to enable technologies for low- and middle-income countries production and use," Bottazzi recalls.

So they turned to private philanthropies. A major donor early on was the JPB Foundation in New York.

"The rest were all Texas philanthropies: the Kleberg Foundation, the [John S.] Dunn Foundation, Tito's Vodka," Hotez says. The MD Anderson Foundation also chipped in.

"When people say, 'Why did we move [from Washington, D.C.] to Texas?' Well, we knew that this was a great philanthropic environment. So this is really very much a Texas vaccine," although there were other, smaller donors from all over the country.

Hotez says that unlike the mRNA vaccines from Pfizer and Moderna, and the viral vector vaccine from Johnson & Johnson, protein subunit vaccines like CORBEVAX have a track record. So he and Bottazzi were relatively certain CORBEVAX would be safe and effective.

"And it's cheap, a dollar, dollar fifty a dose," Hotez says. "You're not going to get less expensive than that."

Clinical trials showed they were right to be confident CORBEVAX would work. An unpublished study conducted in India involving 3,000 volunteers found the vaccine to be 90% effective in preventing disease cause by the original COVID-19 virus strain and 80% against the delta variant. It's still being tested against omicron.

But CORBEVAX is already entering the real world. Last month, the vaccine received emergency use authorization from regulators in India. An Indian vaccine manufacturer called Biological E Ltd is now making the vaccine. The company says it is producing 100 million doses per month and has already sold 300 million doses to the Indian government.

"The real beauty of the CORBEVAX vaccine that Drs. Hotez and Bottazzi created is that intellectual property of this vaccine will be available to everybody," Keith Martin says. "So you can get manufacturers in Senegal, and South Africa and Latin America to be able to produce this particular vaccine."

By contrast, the makers of Pfizer and Moderna, for example, are not sharing their recipe.

One drawback to the CORBEVAX technology is that it can't be modified as quickly as mRNA vaccines can to adjust to new variants.

That forces public health officials to make difficult choices.

"Something which can be adapted the fastest versus something that can be adapted relatively quickly, but then more importantly can be manufactured at a large global capacity and at a cost of production which is much lower," says Prashant Yadav, senior fellow at at the Center for Global Development in Washington, D.C. The thought is some protection may better than no protection.

Of course, the ideal vaccine would have both qualities, and Hotez is at work trying to develop technologies that can do that.

"There's no issue with pushing innovation," he says. "I think that's one of the really positive features of the U.S. vaccination program for COVID. The problem was it wasn't balanced with a portfolio or oldies but goodies."

Hotez is hoping his oldie but goodie will usher in a brighter future for the world.
 
I wouldn't say it is, 'issues' so far have all been mature adults (the paying football going public to the PL continues to age apace) actual in-stadium incidents are lower than the last know statistic (2016), but the pre-drink routine is often heavier now as is the incidence of Cocaine use at grounds - many suppliers use football grounds as an ideal outlet/exchange market, as it's almost impossible to Police, but it's known it's a key element of feeding county gangs supply chains.

https://www.thesun.co.uk/sport/1716...hugs-surge-violence-exclusive-stadium-tested/

So, I'd look for the cause elsewhere at the moment until one of the incidents can be related to covid - which so far, none have.
I thought it was more down to a change in attitude in how football reacts to these incidents. So in the past games were known to have continued and so it didn't get the same awareness apart from those in that section of the crowd. Whereas now games are being halted until the situation is stable so it's becoming more visible to the public and so just has the appearance of being more common.
 
Today, 14:07
Aubameyang update
Arsenal will be allowed to examine Pierre-Emerick Aubameyang’s health by the Gabonese football federation.

Aubameyang had recently tested positive for coronavirus.

The striker has also been diagnosed with heart lesions due to covid infection.

That could be his career on the down-low because he didn't get vaccinated.